QA: RENOVARO BIOSCIENCES INC. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001527728_2019_RENOVARO_BIOSCIENCES_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001527728')"}

Graph

Absolute values for 0001527728, RENOVARO BIOSCIENCES INC.

  xvar xval
0 AssetsCurrent 15,762,015
1 IntangibleAssetsNetIncludingGoodwill 163,735,459
2 PropertyPlantAndEquipmentNet 27,402
3 remainder_Assets 137,550
4 LiabilitiesCurrent 873,722
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 22,891,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,641,781
9 ResearchAndDevelopmentExpense 616,961
10 remainder_Expenses 3,798,901
11 remainder_Revenues 0
12 remainder_NetIncome -1,094,222
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 179,662,426
1 Liabilities 23,764,722
2 Expenses 8,057,643
3 Revenues 0
4 StockholdersEquity 155,897,704
5 NetIncome -9,151,865
6 ComprehensiveNetIncome -9,151,865
7 BaseVar 106,289,506
8 EconomicCapitalRatio 2.55

Edgar->Model Mapping

Feature Distribution

Change over Time